Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

TheMotleyFool

0 0

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?: https://g.foolcdn.com/editorial/images/702564/person-getting-vaccinated.jpg

In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to develop vaccines for COVID-19 and help us end the outbreak. The pandemic isn't over yet, but Moderna and Novavax have given up substantial chunks of their value in the past year.

There's a simple reason. The market is forward-looking, and right now, it sees the end of the pandemic -- or at least the phase of the pandemic during which there is a dire need for vaccines -- in sight. Where does that leave Moderna and Novavax? Let's examine whether these biotechs are still worth investing in today.

Source Fool.com

Like: 0

MRNA

Share